Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability
The TaqIA single nucleotide variant (SNV) has been tested for association with addictions in a huge number of studies. TaqIA is located in the ankyrin repeat and kinase domain containing 1 gene (ANKK1) that codes for a receptor interacting protein kinase. ANKK1 maps on the NTAD cluster along with th...
| Autores: | , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2020 |
| País: | España |
| Institución: | Universidad Complutense de Madrid (UCM) |
| Repositorio: | Docta Complutense |
| Idioma: | inglés |
| OAI Identifier: | oai:docta.ucm.es:20.500.14352/8196 |
| Acceso en línea: | https://hdl.handle.net/20.500.14352/8196 |
| Access Level: | acceso abierto |
| Palabra clave: | ANKK1 TaqIA DRD2 addictions dopamine neurodevelopment Neurociencias (Medicina) Psiquiatría 2490 Neurociencias 3211 Psiquiatría |
| id |
ES_b5d9c435ac1f6f4e6d690d3b827fa5e9 |
|---|---|
| oai_identifier_str |
oai:docta.ucm.es:20.500.14352/8196 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction VulnerabilityKoeneke, AlejandraPonce Alfaro, GuillermoTroya-Balseca, JohannaPalomo Álvarez, TomásHoenicka, JanetANKK1TaqIADRD2addictionsdopamineneurodevelopmentNeurociencias (Medicina)Psiquiatría2490 Neurociencias3211 PsiquiatríaThe TaqIA single nucleotide variant (SNV) has been tested for association with addictions in a huge number of studies. TaqIA is located in the ankyrin repeat and kinase domain containing 1 gene (ANKK1) that codes for a receptor interacting protein kinase. ANKK1 maps on the NTAD cluster along with the dopamine receptor D2 (DRD2), the tetratricopeptide repeat domain 12 (TTC12) and the neural cell adhesion molecule 1 (NCAM1) genes. The four genes have been associated with addictions, although TTC12 and ANKK1 showed the strongest associations. In silico and in vitro studies revealed that ANKK1 is functionally related to the dopaminergic system, in particular with DRD2. In antisocial alcoholism, epistasis between ANKK1 TaqIA and DRD2 C957T SNVs has been described. This clinical finding has been supported by the study of ANKK1 expression in peripheral blood mononuclear cells of alcoholic patients and controls. Regarding the ANKK1 protein, there is direct evidence of its location in adult and developing central nervous system. Together, these findings of the ANKK1 gene and its protein suggest that the TaqIA SNV is a marker of brain differences, both in structure and in dopaminergic function, that increase individual risk to addiction development.MDPIUniversidad Complutense de Madrid20202020-04-0420202020-04-04journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/8196reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Atribución 3.0 Españahttps://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/81962026-06-02T12:44:21Z |
| dc.title.none.fl_str_mv |
Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability |
| title |
Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability |
| spellingShingle |
Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability Koeneke, Alejandra ANKK1 TaqIA DRD2 addictions dopamine neurodevelopment Neurociencias (Medicina) Psiquiatría 2490 Neurociencias 3211 Psiquiatría |
| title_short |
Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability |
| title_full |
Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability |
| title_fullStr |
Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability |
| title_full_unstemmed |
Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability |
| title_sort |
Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability |
| dc.creator.none.fl_str_mv |
Koeneke, Alejandra Ponce Alfaro, Guillermo Troya-Balseca, Johanna Palomo Álvarez, Tomás Hoenicka, Janet |
| author |
Koeneke, Alejandra |
| author_facet |
Koeneke, Alejandra Ponce Alfaro, Guillermo Troya-Balseca, Johanna Palomo Álvarez, Tomás Hoenicka, Janet |
| author_role |
author |
| author2 |
Ponce Alfaro, Guillermo Troya-Balseca, Johanna Palomo Álvarez, Tomás Hoenicka, Janet |
| author2_role |
author author author author |
| dc.contributor.none.fl_str_mv |
Universidad Complutense de Madrid |
| dc.subject.none.fl_str_mv |
ANKK1 TaqIA DRD2 addictions dopamine neurodevelopment Neurociencias (Medicina) Psiquiatría 2490 Neurociencias 3211 Psiquiatría |
| topic |
ANKK1 TaqIA DRD2 addictions dopamine neurodevelopment Neurociencias (Medicina) Psiquiatría 2490 Neurociencias 3211 Psiquiatría |
| description |
The TaqIA single nucleotide variant (SNV) has been tested for association with addictions in a huge number of studies. TaqIA is located in the ankyrin repeat and kinase domain containing 1 gene (ANKK1) that codes for a receptor interacting protein kinase. ANKK1 maps on the NTAD cluster along with the dopamine receptor D2 (DRD2), the tetratricopeptide repeat domain 12 (TTC12) and the neural cell adhesion molecule 1 (NCAM1) genes. The four genes have been associated with addictions, although TTC12 and ANKK1 showed the strongest associations. In silico and in vitro studies revealed that ANKK1 is functionally related to the dopaminergic system, in particular with DRD2. In antisocial alcoholism, epistasis between ANKK1 TaqIA and DRD2 C957T SNVs has been described. This clinical finding has been supported by the study of ANKK1 expression in peripheral blood mononuclear cells of alcoholic patients and controls. Regarding the ANKK1 protein, there is direct evidence of its location in adult and developing central nervous system. Together, these findings of the ANKK1 gene and its protein suggest that the TaqIA SNV is a marker of brain differences, both in structure and in dopaminergic function, that increase individual risk to addiction development. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020 2020-04-04 2020 2020-04-04 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/20.500.14352/8196 |
| url |
https://hdl.handle.net/20.500.14352/8196 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Atribución 3.0 España https://creativecommons.org/licenses/by/3.0/es/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Atribución 3.0 España https://creativecommons.org/licenses/by/3.0/es/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
MDPI |
| publisher.none.fl_str_mv |
MDPI |
| dc.source.none.fl_str_mv |
reponame:Docta Complutense instname:Universidad Complutense de Madrid (UCM) |
| instname_str |
Universidad Complutense de Madrid (UCM) |
| reponame_str |
Docta Complutense |
| collection |
Docta Complutense |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869417397582036992 |
| score |
15.301603 |